Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Although alcohol use disorders (AUDs) are highly prevalent and often disabling, effective pharmacological treatments are underutilised, due partly to clinicians’ lack of knowledge and misperceptions about effectiveness.1 ,2 This systematic review and meta-analysis examined research literature on the efficacy of pharmacotherapies for AUDs in outpatient settings, providing an updated synthesis of effect sizes for a variety of outcomes.
The study reviewed pharmacotherapy studies for AUDs from January 1970 through March 2014, including randomised clinical trials (RCTs) of at least 12 weeks duration in an outpatient setting with alcohol outcomes (eg, return to any drinking, return to heavy drinking), and head-to-head prospective cohort studies with health or adverse effect outcomes. Studies using FDA-approved medications (ie, naltrexone, acamprosate and disulfiram) …
Contributors EMO submitted comments for the commentary and also summarised the method and findings sections.AHSH summarised the context and submitted comments for the commentary section.
Competing interests None.
Provenance and peer review Commissioned; internally peer reviewed.